AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] Amrize Ltd Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Wilbur Maria Cristina Alapag, a director of Amrize Ltd (AMRZ), reported an equity award on 08/11/2025: a grant of 2,958 restricted stock units under the Amrize Ltd 2025 Omnibus Incentive Plan. The award was issued with a $0 purchase price and will vest on the earlier of the one-year anniversary of the grant date or the issuer's next regular annual meeting of shareholders.

After the reported transaction the reporting person held 3,148 ordinary shares beneficially. The filing is a routine director equity award that documents the grant size, vesting condition, and post-transaction ownership level.

Wilbur Maria Cristina Alapag, direttrice di Amrize Ltd (AMRZ), ha segnalato un riconoscimento azionario in data 08/11/2025: una concessione di 2,958 unità azionarie vincolate (restricted stock units) nell'ambito del Amrize Ltd 2025 Omnibus Incentive Plan. L'assegnazione è stata emessa con un prezzo di acquisto di $0 e maturerà al primo verificarsi tra il primo anniversario della data di concessione e la prossima assemblea annuale ordinaria degli azionisti dell'emittente.

Dopo la transazione segnalata, la persona che ha effettuato la comunicazione deteneva beneficiariamente 3,148 azioni ordinarie. Il deposito è una comunicazione di routine relativa a un premio azionario per un membro del consiglio che documenta la dimensione della concessione, la condizione di maturazione e il livello di partecipazione dopo la transazione.

Wilbur Maria Cristina Alapag, directora de Amrize Ltd (AMRZ), informó una adjudicación de acciones el 08/11/2025: una concesión de 2,958 unidades restringidas (RSU) en el marco del Amrize Ltd 2025 Omnibus Incentive Plan. El premio se emitió con un precio de compra de $0 y se consolidará cuando ocurra primero: el primer aniversario de la fecha de concesión o la próxima junta anual ordinaria de accionistas del emisor.

Tras la operación comunicada, la persona informante poseía a título beneficiario 3,148 acciones ordinarias. La presentación es una adjudicación rutinaria a un director que documenta el tamaño de la concesión, la condición de consolidación y el nivel de propiedad tras la operación.

Wilbur Maria Cristina Alapagë‹˜ì€ Amrize Ltd(AMRZ)ì� ì´ì‚¬ë¡œì„œ 2025ë…� 08/11ì—� 주ì‹ë³´ìƒ ë‚´ì—­ì� 보고했습니다: Amrize Ltd 2025 Omnibus Incentive Planì—� 따른 2,958 제한주ì‹ë‹¨ìœ„(RSU)ì� 부여입니다. ì� ë³´ìƒì€ $0ì� ì·¨ë“ê°€ë¡� 발행ë˜ì—ˆìœ¼ë©°, 부여ì¼ë¡œë¶€í„� 1ë…„ì´ ë˜ëŠ” ë‚� ë˜ëŠ” 발행회사ì� ë‹¤ìŒ ì •ê¸° 주주ì´íšŒ ì¤� 먼저 ë„래하는 시ì ì—� ì·¨ë“ê¶Œì´ ë°œìƒí•©ë‹ˆë‹�.

ë³´ê³ ë� 거래 ì´í›„ ë³´ê³ ì¸ì€ 실질ì ìœ¼ë¡� 3,148 보통주를 보유하고 있었습니ë‹�. ì´ë²ˆ ì‹ ê³ ëŠ� ì´ì‚¬ì—게 통ìƒì ìœ¼ë¡� 부여ë˜ëŠ� 주ì‹ë³´ìƒìœ¼ë¡œ, ë¶€ì—� ê·œëª¨Â·ì·¨ë“ ì¡°ê±´Â·ê±°ëž˜ í›� 보유 수준ì� 문서화한 것입니다.

Wilbur Maria Cristina Alapag, administratrice d'Amrize Ltd (AMRZ), a déclaré une attribution d'actions le 08/11/2025 : une octroi de 2,958 unités d'actions restreintes dans le cadre du Amrize Ltd 2025 Omnibus Incentive Plan. L'attribution a été émise avec un prix d'achat de $0 et deviendra acquise au premier des événements suivants : le premier anniversaire de la date d'octroi ou la prochaine assemblée générale annuelle ordinaire de l'émetteur.

Après l'opération signalée, le déclarant détenait à titre bénéficiaire 3,148 actions ordinaires. Le dépôt constitue une attribution habituelle à un administrateur, documentant la taille de la subvention, la condition d'acquisition et le niveau de détention après l'opération.

Wilbur Maria Cristina Alapag, Direktorin von Amrize Ltd (AMRZ), meldete am 08/11/2025 eine Aktienzuteilung: eine Gewährung von 2,958 Restricted Stock Units im Rahmen des Amrize Ltd 2025 Omnibus Incentive Plan. Die Zuteilung wurde zu einem Kaufpreis von $0 ausgegeben und wird zum früheren Zeitpunkt von erstem Jahrestag der Gewährung oder der nächsten ordentlichen Hauptversammlung des Emittenten fällig.

Nach der gemeldeten Transaktion hielt die meldepflichtige Person wirtschaftlich 3,148 Stammaktien. Die Meldung ist eine routinemäßige Directors-Aktienzuteilung, die Umfang, Vesting-Bedingung und das Besitzniveau nach der Transaktion dokumentiert.

Positive
  • None.
Negative
  • None.

Insights

TL;DR Director received a 2,958-unit RSU grant under the 2025 Omnibus Plan; post-grant ownership is 3,148 shares.

This Form 4 discloses a non-cash, restricted stock unit award to a director with customary vesting tied to time and the next annual meeting. The $0 price indicates an award rather than a market purchase. For investors, this is a routine compensation disclosure that updates insider ownership figures but does not, by itself, change the company’s capital structure or cash position.

TL;DR A standard director compensation grant with time-based vesting; disclosure aligns with Section 16 reporting requirements.

The filing documents an equity-based retention/incentive instrument under the stated Omnibus Incentive Plan. The explicit vesting condition—earlier of one-year anniversary or next annual meeting—is clear and limited in duration. This is a governance-typical disclosure that improves transparency about director incentives and current beneficial ownership.

Wilbur Maria Cristina Alapag, direttrice di Amrize Ltd (AMRZ), ha segnalato un riconoscimento azionario in data 08/11/2025: una concessione di 2,958 unità azionarie vincolate (restricted stock units) nell'ambito del Amrize Ltd 2025 Omnibus Incentive Plan. L'assegnazione è stata emessa con un prezzo di acquisto di $0 e maturerà al primo verificarsi tra il primo anniversario della data di concessione e la prossima assemblea annuale ordinaria degli azionisti dell'emittente.

Dopo la transazione segnalata, la persona che ha effettuato la comunicazione deteneva beneficiariamente 3,148 azioni ordinarie. Il deposito è una comunicazione di routine relativa a un premio azionario per un membro del consiglio che documenta la dimensione della concessione, la condizione di maturazione e il livello di partecipazione dopo la transazione.

Wilbur Maria Cristina Alapag, directora de Amrize Ltd (AMRZ), informó una adjudicación de acciones el 08/11/2025: una concesión de 2,958 unidades restringidas (RSU) en el marco del Amrize Ltd 2025 Omnibus Incentive Plan. El premio se emitió con un precio de compra de $0 y se consolidará cuando ocurra primero: el primer aniversario de la fecha de concesión o la próxima junta anual ordinaria de accionistas del emisor.

Tras la operación comunicada, la persona informante poseía a título beneficiario 3,148 acciones ordinarias. La presentación es una adjudicación rutinaria a un director que documenta el tamaño de la concesión, la condición de consolidación y el nivel de propiedad tras la operación.

Wilbur Maria Cristina Alapagë‹˜ì€ Amrize Ltd(AMRZ)ì� ì´ì‚¬ë¡œì„œ 2025ë…� 08/11ì—� 주ì‹ë³´ìƒ ë‚´ì—­ì� 보고했습니다: Amrize Ltd 2025 Omnibus Incentive Planì—� 따른 2,958 제한주ì‹ë‹¨ìœ„(RSU)ì� 부여입니다. ì� ë³´ìƒì€ $0ì� ì·¨ë“ê°€ë¡� 발행ë˜ì—ˆìœ¼ë©°, 부여ì¼ë¡œë¶€í„� 1ë…„ì´ ë˜ëŠ” ë‚� ë˜ëŠ” 발행회사ì� ë‹¤ìŒ ì •ê¸° 주주ì´íšŒ ì¤� 먼저 ë„래하는 시ì ì—� ì·¨ë“ê¶Œì´ ë°œìƒí•©ë‹ˆë‹�.

ë³´ê³ ë� 거래 ì´í›„ ë³´ê³ ì¸ì€ 실질ì ìœ¼ë¡� 3,148 보통주를 보유하고 있었습니ë‹�. ì´ë²ˆ ì‹ ê³ ëŠ� ì´ì‚¬ì—게 통ìƒì ìœ¼ë¡� 부여ë˜ëŠ� 주ì‹ë³´ìƒìœ¼ë¡œ, ë¶€ì—� ê·œëª¨Â·ì·¨ë“ ì¡°ê±´Â·ê±°ëž˜ í›� 보유 수준ì� 문서화한 것입니다.

Wilbur Maria Cristina Alapag, administratrice d'Amrize Ltd (AMRZ), a déclaré une attribution d'actions le 08/11/2025 : une octroi de 2,958 unités d'actions restreintes dans le cadre du Amrize Ltd 2025 Omnibus Incentive Plan. L'attribution a été émise avec un prix d'achat de $0 et deviendra acquise au premier des événements suivants : le premier anniversaire de la date d'octroi ou la prochaine assemblée générale annuelle ordinaire de l'émetteur.

Après l'opération signalée, le déclarant détenait à titre bénéficiaire 3,148 actions ordinaires. Le dépôt constitue une attribution habituelle à un administrateur, documentant la taille de la subvention, la condition d'acquisition et le niveau de détention après l'opération.

Wilbur Maria Cristina Alapag, Direktorin von Amrize Ltd (AMRZ), meldete am 08/11/2025 eine Aktienzuteilung: eine Gewährung von 2,958 Restricted Stock Units im Rahmen des Amrize Ltd 2025 Omnibus Incentive Plan. Die Zuteilung wurde zu einem Kaufpreis von $0 ausgegeben und wird zum früheren Zeitpunkt von erstem Jahrestag der Gewährung oder der nächsten ordentlichen Hauptversammlung des Emittenten fällig.

Nach der gemeldeten Transaktion hielt die meldepflichtige Person wirtschaftlich 3,148 Stammaktien. Die Meldung ist eine routinemäßige Directors-Aktienzuteilung, die Umfang, Vesting-Bedingung und das Besitzniveau nach der Transaktion dokumentiert.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wilbur Maria Cristina Alapag

(Last) (First) (Middle)
GRAFENAUWEG 8

(Street)
ZUG V8 6300

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Amrize Ltd [ AMRZ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 08/11/2025 A 2,958(1) A $0 3,148 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on the earlier of the one-year anniversary of the grant date and the date of the issuer's next regular annual meeting of shareholders.
Hans Weinburger, Attorney-in-Fact 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Wilbur Maria Cristina Alapag report on Form 4 for AMRZ?

The report discloses a grant of 2,958 restricted stock units (RSUs) to the reporting person under the Amrize Ltd 2025 Omnibus Incentive Plan.

When was the RSU award for AMRZ reported and what is the vesting condition?

The transaction date shown is 08/11/2025, and the award vests on the earlier of the one-year anniversary of the grant date or the issuer's next regular annual meeting of shareholders.

Did the director pay cash for the shares reported on the Form 4 (AMRZ)?

No cash consideration was reported; the price is shown as $0, indicating a grant rather than a purchase.

How many AMRZ shares does the reporting person own after the transaction?

The filing reports 3,148 ordinary shares beneficially owned following the reported transaction.

What role does the reporting person hold at Amrize Ltd (AMRZ)?

The Form 4 indicates the reporting person, Wilbur Maria Cristina Alapag, is a Director of Amrize Ltd.
Amrize Ltd

NYSE:AMRZ

AMRZ Rankings

AMRZ Latest News

AMRZ Latest SEC Filings

AMRZ Stock Data

28.74B
493.12M
7.13%
36.87%
0.56%
Building Materials
Cement, Hydraulic
Switzerland
ZUG